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Relationship of Alcohol and Age Cohort to 
Non-Medical Use of Prescription Drugs
Previous efforts to develop an “empirical typology” 
(Braucht, Kirby & Berry, 1978) of drug users have had 
mixed conclusions about the association of alcohol 
abuse and dependence (AUD) with illicit drugs.  The 
strongest associations have been found between 
alcohol use and sedative use.  
The relationship between alcohol use disorders and 
non-medical use of prescription drugs (NMUPD) was 
explored by McCabe, Cranford and Boyd (2006); the 
prevalence of NMUPD was increased among those 
with an AUD, especially among those 18 -24. 
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The Prescription Drug Misuse, Abuse and Dependence 
(R01DA020791) Study (Cottler, LB, PI) aimed to 
evaluate the test-retest reliability and validity of the 
Substance Abuse Module questions, criteria, and 
abuse of and dependence on each category of 
prescription drugs, and to understand contextual 
factors related to prescription drug misuse. All 
variables were based on self-report.  
The sample for these analyses was limited to those 
with past year use of alcohol. 
Age of respondents was collapsed into three groups:  
those 18 to 26, those 27 to 49, and those 50 to 65 
years of age.  Sex was self-reported male or female. 
Lifetime AUDs were assessed according to the DSM-IV 
criteria, collapsed into none versus abuse or 
dependence. 
NMUPD was measured by adding the number of days 
of reported use out of 365 when not prescribed and 
number of days used differently than prescribed. 
Sedatives, stimulants and opiates were asked 
separately; for NMUPD answers were summed 
(theoretical range 0 – 2190). 
Univariate and bivariate analyses were conducted.
NIDA R01DA020791 Prescription Drug Misuse, Abuse 
and Dependence (Linda B. Cottler, PI.). 
We had the opportunity to examine the relationship 
between lifetime AUDs and NMUPD (sedatives, 
stimulants and opioids) in a sample of 400 current 
prescription drug users between the ages of 18 and 65 
who reside in the St. Louis area.  
Regression of alcohol dependence, sex and age 
cohort on days of NMU of Opiates  (N=323)
Regression of alcohol dependence , sex and age 
cohort on days of NMU of Stimulants (N=324)
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The model of NMUPD with robust estimators was not 
significant for AUD, but was significant for age. 
Exploring the influence of age group by prescription 
drug type, we found that younger users were more 
likely to use opiates, and older users were more likely 
to use stimulants non-medically (Shown in Regression 
Result Tables). 
Those with alcohol dependence were more likely to 
report NMU of opiates and stimulants, controlling for 
age and sex, after robust estimators were used to 
account for large differences in variation (See Tables).
The sedative model was not significant for any 
variable, including having a lifetime AUD (Results not 
shown).
Results continued
We regressed Alcohol Dependence (Y/N), sex and age 
cohort on NMUPD SAS.  Using the same predictors, we 
also regressed them on NMU of stimulants, opiates and 
sedatives, in separate models. 
Variance in the range of days used by age cohort were 
large; robust sandwich estimation was necessary.  Final 
regression models were calculated in STATA 10 with 
robust estimators.
Although we investigated the role of alcohol use in 
NMUPD, it proved to have no explanatory power when 
the prescription drug types were combined, unlike 
McCabe and ssociates findings (2006). When drugs 
were separated by class, using robust estimates of 
standard errors, having a lifetime AUD increased the 
likelihood of non-medical use of prescription opiates 
and stimulants. Nevertheless, models had little 
explanatory power.  
Our findings support differences in prevalence of 
prescription drug misuse by age cohort when 
categories of drugs were separated. Non-medical 
pres ription drug use was expected to vary by age 
cohort, with less use in older cohorts. But among non-
medical users of prescription drugs, older adults are 
more likely to have opiates available. Similarly, the 
young adult cohort is more likely to have a prescription 
stimulant available to misuse, or to know a friend with 
a prescription. Availability may partially explain the 
differences by age cohort. 
We found no differences in sedative misuse by age 
group, nor evidence for the anticipated role of AUDs.
Results
AUDs had no relationship to any NMUPD (F=2.44, ns), 
controlling for age group and gender (Model F=3.23, 
p=0.022) in SAS. Age cohorts were significantly different 
for stimulants and opiates in separate models; alcohol 
and gender differences were not significant.
All models were rerun in STATA with robust standard 
errors estimators.
Variable* Coef.   Robust SE t P>t 95% CI
AUD 43.90 15.96 2.755 0.006 12.51,75.30
Female 25.40 15.52 1.64 0.103 -5.14,55.94
27-49 yr olds 66.05 14.87 4.44 0.000 36.79,95.31
50-65 yr olds 69.11 19.45 3.55 0.000 30.85,107.37
Variable Coef.   Robust SE   t P>t 95% CI
AUD 10.31 4.65 2.21 0.027 1.15,19.46
Female 4.19 5.81 0.72 0.471 -7.24,15.62
27 -49 yr olds -21.23 7.22 -2.94 0.004 -35.44,-7.02
50-65 yr olds -26.43 6.66 -3.97 0.000 -39.54,-13.32
Overall model F(4,318)=7.38, p=0.000; R2=0.08
*Reference groups: no lifetime AUD, male, 18 – 26 years old.
Overall model F(4,319)=4.48, p=0.0016; R2=0.06
*Reference groups: no lifetime AUD, male, 18 – 26 years old.
Dependent Variables Mean   Std. Dev. Range
NMU Sed 59.09      115.93 0-730
NMU Stim 10.89 45.44 0-425
NMU Opi 97.99      134.04 0-730
NMU PD 167.49    215.12 0-1458
Independent Variables Freq.    Percent
Had lifetime AUD 265 82%
Female 131 40%
Age Cohort  18 – 26 104 32%
27 – 49 137 42%
Descriptive Statistics (N=324)
